Two More Altcoins Came from Coinbase: Listed on the Road Map! - Coin Bulletin

Koinbulteni · 2025-07-28T23:00:34+00:00

Coinbase announced the addition of Bio Protocol (BIO) and Euler (EUL) to its roadmap for potential future listings, aiming to provide users with diverse investment opportunities while adhering to legal and technical standards.

Koinbulteni

2025-07-28 23:00:34

Abstract generation in progress

In an official statement made on July 29, Coinbase announced that it has added Bio Protocol (BIO) and Euler (EUL) to its roadmap, which includes cryptocurrencies that have undergone technical and legal evaluations before being listed on the platform. The company aims to provide its users with broader and more diverse investment opportunities with the addition of new assets.

Coinbase had shared its goal of incorporating more cryptocurrencies into its ecosystem in recent months. In this context, the giant exchange, which opened many different altcoins for trading to its users, announced that it considers Bio Protocol (BIO) and Euler (EUL) as assets with potential for future listings.

div[id^=“wrapper-sevio-b3ce5b60-2c13-4244-9d7d-ac51d3cdb72e”] { display: inline-block; padding-top: 10px; padding-bottom: 10px; }

@media only screen and (min-width: 0px) and (min-height: 0px) { div[id^=“wrapper-sevio-b3ce5b60-2c13-4244-9d7d-ac51d3cdb72e”] { width: 320px; height: 100px; } }

@media only screen and (min-width: 728px) and (min-height: 0px) { div[id^=“wrapper-sevio-b3ce5b60-2c13-4244-9d7d-ac51d3cdb72e”] { width: 728px; height: 90px; } }

The company’s blog post drew attention with its explanation of the asset selection criteria:

As we stated during the launch of Asset Hub, our goal is to list every possible asset that meets our legal, compliance, and technical security standards. These standards do not take into account a project’s market value or popularity.

Coinbase emphasized that it pays special attention to listing cryptocurrencies that operate on different networks and have unique systemic features. The addition of Bio Protocol (BIO) and Euler (EUL) to the roadmap was seen as part of the exchange’s diversification and innovation strategy.

The exchange stated that the trading of the relevant assets is dependent on the provision of market maker support and adequate technical infrastructure, and that an announcement regarding the initiation of trading will be made after these conditions are met.

According to CoinGecko data, BIO lost 2.3% in value in the last 24 hours, while EULER experienced an increase of 1.25% during the same period.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.